Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet function testing-guided short-term prasugrel followed by clopidogrel versus 12-month prasugrel in ACS patients undergoing PCI
2013-001636-22Phase 4Completed
- Sponsor
- LMU Klinikum
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel and clopidogrel in acute coronary syndrome (ACS) (2 arms), sponsored by LMU Klinikum. Primary endpoint: Primary composite endpoint. Started Jun 2013; status: completed.
02
Drugs
prasugrelclopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2013-001636-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001636-22.